HDAC2 and cancer: Existing data has implied that Lsh interacts predominantly with the de novo methyltransferases Dnmt3a and Dnmt3b in MEFs, while this interaction occurs by means of HDAC1 and HDAC2 in transformed cancer cells (HCT116) [27].